Calidi Biotherapeutics, Inc. (CLDI) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45K | 405K | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | -100% | -100% | - | - | - | - | - |
| Cost of Goods Sold | 426K | 0 | 0 | 0 | 0 | 393K | 0 | 0 | 374K | 364K | 100K | 364K | 183K | 0 | 0 | 0 | 14K | 50K | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 31.11% | 12.35% | - |
| Gross Profit | -426K | 0 | 0 | 0 | 0 | -393K | 0 | 0 | -374K | -364K | -100K | -364K | -183K | 0 | 0 | 0 | 31K | 355K | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 68.89% | 87.65% | - |
| Gross Profit Growth % | - | 100% | - | - | 100% | -7.97% | 100% | 100% | -104.37% | - | - | - | -690.32% | -100% | - | - | - | - | - |
| Operating Expenses | 3.76M | 4.47M | 5.05M | 5.66M | 5.06M | 3.63M | 5.23M | 5.77M | 6.38M | 9.46M | 7.12M | 6.17M | 5.23M | 4.69M | 6.99M | 4.38M | 7.1M | 3.32M | 1.09M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 15784.44% | 819.75% | - |
| Selling, General & Admin | 1.6M | 2.11M | 2.69M | 3.07M | 2.64M | 1.82M | 3.07M | 3.6M | 3.63M | 5.5M | 3.87M | 3M | 2.61M | 6.63M | 3.14M | 2.9M | 3.44M | 1.95M | 1.09M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7640% | 480.25% | - |
| Research & Development | 2.59M | 2.36M | 2.36M | 2.59M | 2.42M | 1.81M | 2.15M | 2.17M | 2.74M | 3.96M | 3.25M | 3.18M | 2.62M | 2.26M | 1.95M | 1.48M | 1.56M | 1.25M | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3477.78% | 307.65% | - |
| Other Operating Expenses | -426K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1000K | 1000K | 0 | 1000K | 129K | 0 |
| Operating Income | -4.19M | -4.47M | -5.05M | -5.66M | -5.06M | -4.03M | -5.23M | -5.77M | -6.75M | -9.82M | -7.22M | -6.54M | -5.41M | -4.69M | -6.99M | -4.38M | -7.07M | -2.96M | -1.09M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -15715.56% | -732.1% | - |
| Operating Income Growth % | 17.29% | -10.93% | 3.41% | 1.87% | 25.03% | 59% | 27.63% | 11.7% | -24.71% | -109.47% | -3.36% | -49.18% | 23.44% | -58.11% | -538.06% | - | - | - | - |
| EBITDA | -3.76M | -4.04M | -4.62M | -5.26M | -4.67M | -3.63M | -4.84M | -5.39M | -6.38M | -9.46M | -6.88M | -6.17M | -5.23M | -4.59M | -6.92M | -4.33M | -7.02M | -2.92M | -823.29K |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -15600% | -720.25% | - |
| EBITDA Growth % | 19.43% | -11.29% | 4.45% | 2.54% | 26.81% | 61.58% | 29.67% | 12.62% | -21.93% | -106.01% | 0.69% | -42.43% | 25.48% | -57.35% | -741.02% | - | - | - | - |
| D&A (Non-Cash Add-back) | 426K | 423K | 427K | 407K | 394K | 393K | 390K | 378K | 374K | 364K | 345K | 364K | 183K | 98K | 62K | 48K | 52K | 48K | 0 |
| EBIT | -4.07M | -4.02M | -5.13M | -5.71M | -4.99M | -3.97M | -4.84M | -5.49M | -6.97M | -8.01M | -1.69M | -12.19M | -6.24M | -8.89M | -5.09M | -4.57M | -4.97M | -2.84M | -823.29K |
| Net Interest Income | -38K | -42K | -41K | -52K | -72K | -175K | -232K | -273K | -253K | -222K | -324K | -306K | -217K | -98K | -29K | 160K | 16.5K | -62K | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 160K | 16.5K | 0 | 0 |
| Interest Expense | 38K | 42K | 41K | 52K | 72K | 175K | 232K | 273K | 253K | 222K | 324K | 306K | 217K | 98K | 29K | - | - | 62K | 0 |
| Other Income/Expense | 83K | 405K | -123K | -93K | 3K | -119K | 156K | 13K | -469K | 1.59M | 5.21M | -5.96M | -1.04M | -3.07M | 1.63M | -183K | -666K | -521K | 271.59K |
| Pretax Income | -4.1M | -4.06M | -5.17M | -5.76M | -5.06M | -4.14M | -5.07M | -5.76M | -7.22M | -8.23M | -2.01M | -12.5M | -6.46M | -7.76M | -5.35M | -4.57M | -7.74M | -3.49M | -823.29K |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -17195.56% | -860.74% | - |
| Income Tax | 4K | -2K | 10K | 4K | 3K | 3K | -1K | 8K | 4K | -3K | 11K | 4K | 4K | -3K | 1K | 11K | 2K | 3K | 0 |
| Effective Tax Rate % | -0.1% | 0.05% | -0.19% | -0.07% | -0.06% | -0.07% | 0.02% | -0.14% | -0.06% | 0.04% | -0.55% | -0.03% | -0.06% | 0.04% | -0.02% | -0.24% | -0.03% | -0.09% | 0% |
| Net Income | -4.11M | -4.06M | -5.15M | -5.71M | -4.99M | -4.1M | -5.05M | -5.77M | -7.22M | -8.23M | -2.02M | -12.5M | -6.46M | -7.76M | -5.36M | -4.58M | -7.74M | -3.49M | -823.29K |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -17200% | -861.48% | - |
| Net Income Growth % | 17.61% | 1% | -1.88% | 0.9% | 30.99% | 50.21% | -149.7% | 53.87% | -11.81% | -6.1% | 62.2% | -173.19% | 16.51% | -122.3% | -550.44% | - | - | - | - |
| Net Income (Continuing) | -4.11M | -4.06M | -5.18M | -5.76M | -5.06M | -4.15M | -5.07M | -5.77M | -7.22M | -8.23M | -2.02M | -12.5M | -6.46M | -7.76M | -5.36M | -4.58M | -7.74M | -3.49M | -823.29K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 280K | 312K | 358K | 434K | 485K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.43 | -0.56 | -2.21 | -1.99 | -2.21 | -3.22 | -7.80 | -16.80 | -24.42 | -27.80 | -16.97 | -51.84 | -27.00 | -31.44 | 2.28 | 17.40 | 6.12 | 17.88 | -3.48 |
| EPS Growth % | 80.54% | 82.61% | 71.67% | 88.15% | 90.95% | 88.42% | 54.04% | 67.59% | 9.56% | 11.58% | -844.3% | -397.93% | -541.18% | -275.84% | 165.52% | - | - | - | - |
| EPS (Basic) | -0.43 | -0.56 | -2.21 | -1.99 | -2.21 | -3.22 | -7.80 | -16.80 | -24.42 | -27.80 | -16.97 | -51.84 | -27.00 | -31.44 | 2.28 | 17.40 | 6.12 | 17.88 | -3.48 |
| Diluted Shares Outstanding | 10.31M | 7.22M | 4.91M | 2.88M | 2.25M | 664.41K | 649.39K | 442.22K | 295.08K | 294.83K | 118.77K | 81.99K | 81.99K | 81.99K | 219.9K | 238.63K | 238.63K | 238.63K | 238.63K |
| Basic Shares Outstanding | 10.31M | 7.22M | 4.91M | 2.88M | 2.25M | 664.41K | 649.39K | 442.22K | 295.08K | 294.83K | 118.77K | 81.99K | 81.99K | 81.99K | 219.9K | 238.63K | 238.63K | 238.63K | 238.63K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |